Position in JNJ
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$24,049,689
+$912,221 QoQ
Shares Held
94,695
+0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.77%
of 13F equity value
Holder Rank
#664
of 4,664 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ELEVATION POINT WEALTH PARTNERS, LLC holds $156,714,234 across 14 Drug Manufacturers - General names. JNJ ranks #2 (15.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
42,067 | $50,456,426 | |
| 2 | JNJ |
Johnson & Johnson
This page
|
94,695 | $24,049,689 | |
| 3 | ABBV |
AbbVie Inc.
|
92,097 | $23,175,289 | |
| 4 | MRK |
Merck & Co., Inc.
|
145,564 | $18,704,974 | |
| 5 | AMGN |
Amgen Inc
|
25,505 | $9,235,870 | |
| 6 | PFE |
Pfizer Inc
|
316,786 | $7,628,206 | |
| 7 | NVS |
Novartis AG
|
47,580 | $7,456,737 | |
| 8 | AZN |
Astrazeneca PLC
|
38,745 | $7,346,826 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,049,689 | 94,695 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $23,137,468 | 94,655 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $12,528,132 | 60,537 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $7,839,001 | 42,277 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,399,702 | 15,710 | Shares | Sole | 2026-02-03 | |
| 2025-03-31 | $2,845,151 | 17,156 | Shares | Sole | 2026-02-03 | |
| 2024-12-31 | $2,656,958 | 18,372 | Shares | Sole | 2026-02-03 | |
| 2024-09-30 | $2,985,793 | 18,424 | Shares | Sole | 2026-02-03 | |
| 2024-06-30 | $3,237,005 | 22,147 | Shares | Sole | 2026-02-03 | |
| 2024-03-31 | $3,488,247 | 22,051 | Shares | Sole | 2026-02-03 | |
| 2023-12-31 | $3,294,361 | 21,018 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $3,372,766 | 21,655 | Shares | Sole | 2023-10-11 | |
| 2023-06-30 | $4,501,978 | 27,199 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $4,356,275 | 28,105 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $4,788,098 | 27,105 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $4,280,848 | 26,205 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $4,683,956 | 26,387 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $4,513,516 | 25,467 | Shares | Sole | 2022-05-03 | |
| 2021-12-31 | $4,058,635 | 23,725 | Shares | Sole | 2022-02-02 | |
| 2021-09-30 | $3,650,707 | 22,605 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $2,878,502 | 17,473 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $2,642,748 | 16,080 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $2,487,390 | 15,805 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $2,310,319 | 15,518 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $1,856,737 | 13,203 | Shares | Sole | 2020-07-09 | |
| 2020-03-31 | $1,441,512 | 10,993 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||